Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 149,562 |
|
|||||
| News | - | ||||||
| Day High | 23.15 | Low High |
|||||
| Day Low | 22.65 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Rocket Pharmaceuticals Inc | RCKT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.47 | 2.08% | 23.09 | 14:15:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 22.70 | 22.65 | 23.15 | 22.62 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,291 | 149,562 | $ 22.88 | $ 3,422,107 | - | 14.89 - 32.525 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:17:45 | 11 | $ 23.12 | USD |
Rocket Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.24M | 90.50M | - | 0 | -245.6M | -2.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Rocket Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RCKT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 22.92 | 24.46 | 22.45 | 23.20 | 458,027 | 0.17 | 0.74% |
| 1 Month | 23.00 | 24.76 | 21.44 | 22.85 | 612,354 | 0.09 | 0.39% |
| 3 Months | 29.30 | 31.47 | 21.44 | 25.58 | 690,809 | -6.21 | -21.19% |
| 6 Months | 22.00 | 32.525 | 21.44 | 26.80 | 753,212 | 1.09 | 4.95% |
| 1 Year | 21.96 | 32.525 | 14.89 | 23.03 | 870,272 | 1.13 | 5.15% |
| 3 Years | 40.63 | 49.66 | 7.565 | 21.03 | 746,676 | -17.54 | -43.17% |
| 5 Years | 17.19 | 67.48 | 7.565 | 23.43 | 599,286 | 5.90 | 34.32% |
Rocket Pharmaceuticals Description
| Rocket Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. |
